Tumor necrosis factor-α and αB-crystallin up-regulation during antibody-mediated demyelination in vitro: A putative protective mechanism in oligodendrocytes

Journal of Neuroscience Research

Volumn 78, Issue 5, 2004, Pages 711-722

  Duvanel, Cécile Besson ^a   Monnet Tschudi, Florianne ^b,c   Braissant, Olivier ^a   Matthieu, Jean Marie ^a   Honegger, Paul ^b  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

^c UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Aggregating brain cell cultures; Apoptosis; Multiple sclerosis; Necrosis

Indexed keywords

ALPHA CRYSTALLIN; HEAT SHOCK PROTEIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL TISSUE; ANTIGEN ANTIBODY COMPLEX; APOPTOSIS; ARTICLE; ASTROCYTE; CELL CULTURE; CELL DEATH; CELL PROTECTION; CELL SURVIVAL; CONTROLLED STUDY; DEMYELINATION; FETUS; IN VITRO STUDY; MICROGLIA; MULTIPLE SCLEROSIS; NONHUMAN; OLIGODENDROGLIA; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; UPREGULATION;

2',3'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASES; ANIMALS; ANTIBODIES; APOPTOSIS; BLOTTING, WESTERN; CELLS, CULTURED; COMPLEMENT SYSTEM PROTEINS; CRYSTALLINS; DEMYELINATING DISEASES; DISEASE MODELS, ANIMAL; DRUG INTERACTIONS; EMBRYO; GLIAL FIBRILLARY ACIDIC PROTEIN; HEME OXYGENASE (DECYCLIZING); HEME OXYGENASE-1; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MYELIN BASIC PROTEINS; MYELIN-ASSOCIATED GLYCOPROTEIN; NECROSIS; NEURONS; OLIGODENDROGLIA; RATS; TELENCEPHALON; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 10644228557     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/jnr.20310     Document Type: Article

References (65)

1. Adelmann M, Wood J, Benzel I, Fiori P, Lassmann H, Matthieu J-M, Gardinier MV, Dornmair K, Linington C. 1995. The N-terminal domain of the myelin oligodendrocyte glycoprotein (MOG) induces acute demyelinating experimental autoimmune encephalomyelitis in the Lewis rat. J Neuroimmunol 63:17-27.
2. Amiguet P, Gardinier MV, Zanetta J-P, Matthieu J-M. 1992. Purification and partial structural and functional characterization of mouse myelin/oligodendrocyte glycoprotein. J Neurochem 58:1676-1682.
3. Arnett HA, Mason J, Marino M, Suzuki K, Matsushima GK, Ting JP-Y. 2001. TNF-α promotes proliferation of oligodendrocyte progenitors and remyelination. Nat Neurosci 4:1116-1122.
4. Bajramovic JJ, Lassmann H, van Noort JM. 1997. Expression of αB-crystallin in glia cells during lesional development in multiple sclerosis. J Neuroimmunol 78:143-151.
5. Bajramovic JJ, Bsibsi M, Geutskens SB, Hassankahn R, Verhulst KC, Stege GJJ, de Groot CJA, van Noort JM. 2000. Differential expression of stress proteins in human adult astrocytes in response to cytokines. J Neuroimmunol 106:14-22.
6. Barnett MH, Prineas JW. 2004. Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion. Ann Neurol 55:458-468.
7. Beere HM, Wolf BB, Cain K, Mosser DD, Mahbouti A, Kuwana T, Tailor P, Morimoto RI, Ghun GM, Green DR. 2000. Heat shock protein 70 inhibits apoptosis by preventing recruitment of procaspase-9 to Apaf-1 apoptosome. Nat Cell Biol 2:469-475.
8. Besson Duvanel C, Honegger P, Matthieu J-M. 2001. Antibodies against Rubella virus induce demyelination in aggregating rat brain cell cultures. J Neurosci Res 65:446-454.
9. Besson Duvanel C, Honegger P, Pershadsingh H, Feinstein D, Matthieu J-M. 2003. Inhibition of glial cell proinflammatory activities by peroxisome proliferator activated receptor gamma agonist confers partial protection during anti-myelin oligodendrocyte glycoprotein demyelination in vitro. J Neurosci Res 71:246-255.
10. Bonetti B, Raine CS. 1997. Multiple sclerosis: oligodendrocytes display cell death-related molecules in situ but do not undergo apoptosis. Ann Neurol 42:74-84.
11. Bonetti B, Pohl J, Gao YL, Raine CS. 1997. Cell death during autoimmune demyelination: effector but not target cells are eliminated by apoptosis. J Immunol 159:5733-5741.
12. Braissant O. 2004. Measurement of nitric oxide-related enzymes in brain by in situ hybridization. Methods Mol Biol 279:113-124.
13. Brockhaus M, Schoenfeld HJ, Schlaeger EJ, Hunziker W, Lesslauer W, Loetscher H. 1990. Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies. Proc Natl Acad Sci USA 87:3127-3131.
14. Brosnan CF, Raine CS. 1996. Mechanisms of immune injury in multiple sclerosis. Brain Pathol 6:243-257.
15. Bruce AJ, Boling W, Kindy MS. 1996. Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors. Nat Med 2:788-794.
16. Brunner C, Lassmann H, Waehneldt TV, Matthieu J-M, Linington C. 1989. Differential ultrastructural localization of myelin basic protein, myelin/oligodendroglial glycoprotein, and 2′,3′-cyclic nucleotide 3′-phosphodiesterase in the CNS of adult rats. J Neurochem 52:296-304.
17. Bürgisser P. 1983. Mise au point d'un dosage radioimmunologique de la protéine basique de la myéline dans le liquide céphalorachidien et dans le tissus nerveux. MD thesis, Université de Lausanne, Lausanne, Switzerland.
18. Calabrese V, Scapagnini G, Ravagna A, Giuffrida Stella AM, Butterfield DA. 2002. Molecular chaperones and their roles in neural cell differentiation. Dev Neurosci 24:1-13.
19. Casaccia-Bonnefil P. 2000. Cell death in the oligodendrocyte lineage: a molecular perspective of life/death decisions in development and disease. Glia 29:124-135.
20. Clark JI, Muchowski PJ. 2000. Small heat-shock proteins and their potential role in human disease. Curr Opin Struct Biol 10:52-59.
21. Dowling P, Shang G, Raval S, Menonna J, Cook S, Husar W. 1996. Involvement of the CD95 (APO-1, fas) receptor/ligand system in multiple sclerosis brain. J Exp Med 184:1513-1518.
22. D'Souza SD, Alinaukas K, McCrae E, Goodyer C, Antel JP. 1995. Differential susceptibility of human CNS-derived cell populations to TNF-dependent and independent immune-mediated injury. J Neurosci 15:7293-7300.
23. Eizenberg O, Faber-Elman A, Gottlieb E, Oren M, Rotter V, Schwartz M. 1995. Direct involvement of p53 in programmed cell death of oligodendrocytes. EMBO J 14:1136-1144.
24. Elenkov IJ, Kovacs K, Duda E, Stark E, Vizi ES. 1992. Presynaptic inhibitory effect of TNFα on the release of noradrenaline in isolated median eminence. J Neuroimmunol 41:117-120.
25. Gadient RA, Cron KC, Otten U. 1990. Interleukin-1β and tumor necrosis factor α synergistically stimulate nerve growth factor (NGF) release from cultured astrocytes. Neurosci Lett 117:335-340.
26. Garrido C, Gurbuxani S, Ravagnan L, Kroemer G. 2001. Heat shock proteins: endogenous modulators of apoptotic cell death. Biochem Biophys Res Commun 286:433-442.
27. Gausas J, Paterson PY, Day AD, Dal Canto MC. 1992. Intact B-cell activity is essential for complete expression of experimental allergic encephalomyelitis in Lewis rats. Cell Immunol 72:360-366.
28. Genain CP, Cannella B, Hauser SL, Raine CS. 1999. Identification of autoantibodies associated with myelin damage in multiple sclerosis. Nature Med 5:170-175.
29. Goldbaum O, Richter-Landsberg C. 2001. Stress proteins in oligodendrocytes: differential effects of heat shock and oxidative stress. J Neurochem 78:1233-1242.
30. Hightower LE. 1991. Heat shock, stress proteins, chaperones and proteotoxicity. Cell 66:191-197.
31. Hisahara S, Okano H, Miura M. 2003. Caspase-mediated oligodendrocyte cell death in the pathogenesis of autoimmune demyelination. Neurosci Res 46:387-397.
32. Honegger P, Matthieu J-M. 1990. Aggregating brain cell cultures: A model to study myelination and demyelination. In: Jeserich G, Althaus HH, Waeneldt TV, editors. Cellular and molecular biology of myelination. Berlin: Springer Verlag, p 155-170.
33. Honegger P, Monnet-Tschudi F. 2001. Aggregating neural cell cultures. In: Fedoroff S, Richardson A, editors. Protocols for neural cell cultures. Totowa, NJ: Humana Press, p 199-218.
34. Kamradt MC, Chen F, Cryns VL. 2001. The small heat shock protein αB-crystallin negatively regulates cytochrome c- and caspase-8-dependent activation of caspase-3 by inhibiting its autoproteolytic maturation. J Biol Chem 61:456-461.
35. Kerlero de Rosbo N, Honegger P, Lassmann H, Matthieu J-M. 1990. Demyelination induced in aggregating rat brain cell cultures by a monoclonal antibody against myelin oligodendrocyte glycoprotein. J Neurochem 55:583-587.
36. Kornek B, Lassmann H. 2003. Neuropathology of multiple sclerosis-new concepts. Brain Res Bull 61:321-326.
37. Kurihara T, Tsukada Y. 1967. The regional and subcellular distribution of 2′,3′-cyclic nucleotide 3′-phosphohydrolase in the central nervous system. J Neurochem 14:1167-1174.
38. Linington C, Lassmann H. 1987. Antibody responses in chronic relapsing experimental allergic encephalomyelitis: correlation of serum demyelinating activity with antibody titre to the myelin oligodendrocyte glycoprotein. J Neurochem 17:61-69.
39. Linington C, Webb M, Woodhams PL. 1984. A novel myelin-associated glycoprotein defined by a mouse monoclonal antibody. J Neuroimmunol 6:387-396.
40. Liu J, Marino MW, Wong G, Grail D, Dunn A, Bettadapura J, Slavin AJ, Old L, Bernard CC. 1998. TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination. Nat Med 4:78-83.
41. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. 1951. Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275.
42. Lucchinetti CF, Brück W, Rodriguez M, Lassmann H. 1996. Distinct patterns of multiple sclerosis pathology indicates heterogeneity of pathogenesis. Brain Pathol 6:259-274.
43. Matejuk A, Dwyer J, Ito A, Bruender Z, Vandenbark AA, Offner H. 2002. Effects of cytokine deficiency on chemokine expression in CNS mice with EAE. J Neurosci Res 67:680-688.
44. Merrill JE, Benveniste EN. 1996. Cytokines in inflammatory brain lesions: helpful and harmful. Trends Neurosci 19:331-338.
45. Merrill JE, Scolding NJ. 1999. Mechanisms of damage to myelin and oligodendrocytes and their relevance to disease. Neuropathol Appl Neurobiol 25:435-458.
46. Nagata S. 1997. Apoptosis by death factor. Cell 88:355-365.
47. Pandey P, Saleh A, Nakazawa A, Kumar S, Srinivasula SM, Kumar V, Weichselbaum R, Nalin C, Alnemri ES, Kufe D, Kharbanda S. 2000. Negative regulation of cytochrome c-mediated oligomerization of Apaf-1 and activation of procaspase-9 by heat shock protein 90. EMBO J 19:4310-4322.
48. Patel AJ, Hunt A, Gordon RD, Balazs R. 1982. The activities in different neural cell types of certain enzymes associated with metabolic compartmentation of glutamate. Brain Res Dev Brain Res 4:3-11.
49. Pouly S, Storch MK, Matthieu JM, Lassmann H, Monnet-Tschudi F, Honegger P. 1997. Demyelination induced by protein kinase C-activating tumor promoters in aggregating brain cell cultures. J Neurosci Res 49:1-12.
50. Pouly S, Matthieu J-M, Honegger P. 2001. Remyelination in vitro following protein kinase C activator-induced demyelination. Neurochem Res 6:619-627.
51. Raine CS. 1997. The Norton Lecture: a review of the oligodendrocyte in the multiple sclerosis lesion. J Neuroimmunol 77:135-152.
52. Saleh A, Srinivasula SM, Balkir L, Robbins PD, Alnemri ES. 2000. Negative regulation of the Apaf-1 apoptosome by Hsp 70. Nat Cell Biol 2:476-483.
53. Schipper HM. 2000. Heme oxygenase-1: role in brain aging and neurodegeneration. Exp Gerontol 35:821-830.
54. Scolding NJ, Morgan BP, Campbell AK, Compston DA. 1990. Complement mediate serum cytotoxicity against oligodendrocytes: a comparison with other cells of the oligodendrocyte-type 2 astrocyte lineage. J Neurol Sci 97:155-162.
55. Selmaj KW, Raine CS. 1988. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann Neurol 23:339-346.
56. Selmaj KW, Raine CS, Farooq M, Norton WT, Brosnan CF. 1991. Cytokine cytotoxicity against oligodendrocytes. Apoptosis induced by lymphotoxin. J Immunol 147:1522-1529.
57. Sharp BM, Matta SG, Peterson PK, Newton R, Chao C, McCallen K. 1989. Tumor necrosis factor is a potent ACTH secretagogue: comparison to interleukin-1β. Endocrinology 124:3131-3133.
58. Shin SL, Cha JH, Chun MH, Chung JW, Lee MY. 1999. Expression of osteopontin mRNA in the adult rat brain. Neurosci Lett 273:73-76.
59. Storch MK, Piddlesden S, Haltia M, Iivanainen M, Morgan P, Lassmann H. 1998. Multiple sclerosis: in situ evidence for antibody and complement mediated demyelination. Ann Neurol 43:465-471.
60. The Lenercept Group. 1999. TNF neutralization in MS: results of a randomized, placebo-controlled multicenter study. Neurology 53:457-465.
61. Tosic M, Rakic S, Matthieu J-M, Zecevic N. 2002. Identification of Golli and myelin basic proteins in human brain during early development. Glia 37:219-228.
62. Van Noort JM, Van Sechel AC, Bajramovic JJ, El Ouagmiri M, Polman CH, Lassmann H, Ravid R. 1995. The small heat shock protein αB-crystallin as candidate autoantigen in multiple sclerosis. Nature 375:798-801.
63. Van Oosten BW, Barklof F, Trugen L, Borsiga JB, Bertelsman FW, von Blomberg BM, Woody JN, Hartung HP, Polman CH. 1996. Increased MRI activity and immune activation in two multiple sclerosis patients treated with monoclonal anti-tumor necrosis factor antibody cA2. Neurology 47:1531-1534.
64. Villarroya H, Marie Y, Ouallet J-C, Le Saux F, Tchélingé rian J-L, Baumann N. 1997. Expression of TNFα in central neurons of Lewis rat spinal cord after EAE induction. J Neurosci Res 49:592-599.
65. Wilson SH, Schrier BK, Farber JL, Thompson EJ, Rosenberg RN, Blume AJ, Nirenberg MW. 1972. Markers for gene expression in cultured cells from the nervous system. J Biol Chem 247:3159-3169.